Literature DB >> 14513425

Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae.

Lisa J Moore1, Alison C Pridmore, Steven K Dower, Robert C Read.   

Abstract

The Streptococcus pneumoniae cell-wall components peptidoglycan and lipoteichoic acid activate Toll-like receptor 2 (TLR2), which transduces an inflammatory response. After exposure to penicillin, type 2 S. pneumoniae strain D39, but not the isogenic autolysin-deficient mutant AL2, induced significantly enhanced interleukin-8 promoter activity in TLR2-transfected HeLa cells. Lag-phase D39 exhibited enhanced TLR2 activation after exposure to penicillin at levels below the minimum inhibitory concentration (MIC); in contrast, early log-phase S. pneumoniae were most active when exposed to the MIC. This enhancement was not ablated by heat treatment but was attenuated by autolysin inhibitors. The antimicrobial activity of moxifloxacin and erythromycin was not associated with TLR2 activation by S. pneumoniae. These data show that penicillin treatment of S. pneumoniae releases proinflammatory cell-wall components that activate TLR2 and that this activity is dependent on autolysin, the growth phase of the organism, and the antibiotic concentration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513425     DOI: 10.1086/378238

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Modifications to the peptidoglycan backbone help bacteria to establish infection.

Authors:  Kimberly M Davis; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 2.  Inflammatory properties of antibiotic-treated bacteria.

Authors:  Andrea J Wolf; George Y Liu; David M Underhill
Journal:  J Leukoc Biol       Date:  2016-08-30       Impact factor: 4.962

Review 3.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid.

Authors:  Ho Seong Seo; Je Hak Kim; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2006-04

5.  A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection.

Authors:  Kevin Fabrizio; Abraham Groner; Marianne Boes; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

6.  Lgt processing is an essential step in Streptococcus suis lipoprotein mediated innate immune activation.

Authors:  Paul J Wichgers Schreur; Johanna M J Rebel; Mari A Smits; Jos P M van Putten; Hilde E Smith
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

Review 7.  Immunomodulators as an antimicrobial tool.

Authors:  Liise-anne Pirofski; Arturo Casadevall
Journal:  Curr Opin Microbiol       Date:  2006-08-22       Impact factor: 7.934

8.  Streptococcus pneumoniae stabilizes tumor necrosis factor alpha mRNA through a pathway dependent on p38 MAPK but independent of Toll-like receptors.

Authors:  Trine H Mogensen; Randi S Berg; Lars Ostergaard; Søren R Paludan
Journal:  BMC Immunol       Date:  2008-09-16       Impact factor: 3.615

9.  Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis.

Authors:  Hakim Echchannaoui; Stephen L Leib; Ulf Neumann; Regine M A Landmann
Journal:  BMC Infect Dis       Date:  2007-04-11       Impact factor: 3.090

10.  Heterogeneity of host TLR2 stimulation by Staphylocoocus aureus isolates.

Authors:  Dina Hilmi; Marijo Parcina; Daniel Stollewerk; Jenny Ostrop; Michaele Josten; Alina Meilaender; Ulrich Zaehringer; Thomas A Wichelhaus; Gabriele Bierbaum; Klaus Heeg; Christiane Wolz; Isabelle Bekeredjian-Ding
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.